HRH3 and attention deficit-hyperactivity disorder: Most studies have chosen to target H3R, a presynaptic autoreceptor that regulates dopamine, acetylcholine, and histamine release via negative feedback, which has also been associated with other neurologic disorders such as Alzheimer’s disease and attention deficit hyperactive disorder (ADHD) [59,60].